Magnani John L. 4
4 · GLYCOMIMETICS INC · Filed Dec 23, 2019
Insider Transaction Report
Form 4
Magnani John L.
DirectorVP of Research, CSO
Transactions
- Exercise/Conversion
Common Stock
2019-12-20$1.12/sh+106,984$119,822→ 182,777 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-12-20−106,984→ 106,983 totalExercise: $1.12Exp: 2021-01-04→ Common Stock (106,984 underlying)
Holdings
- 4,845(indirect: By GlycoTech Corporation)
Common Stock
Footnotes (2)
- [F1]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
- [F2]One-fourth of the shares underlying this option vested on January 4, 2012, with the remainder vesting in 36 equal monthly installments thereafter.